Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | AZD3470 |
| Synonyms | |
| Therapy Description |
AZD3470 inhibits PRMT5, potentially resulting in decreased tumor cell proliferation (Blood (2024) 144 (Supplement 1): 1674.2, NCI Drug Dictionary). |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| AZD3470 | AZD 3470|AZD-3470 | PRMT5 Inhibitor 21 | AZD3470 inhibits PRMT5, potentially resulting in decreased tumor cell proliferation (Blood (2024) 144 (Supplement 1): 1674.2, NCI Drug Dictionary). |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|---|---|---|---|---|---|
| NCT06137144 | Phase Ib/II | AZD3470 | AZD3470 as Monotherapy and in Combination With Anticancer Agents in Participants With Relapsed/Refractory Haematologic Malignancies. (PRIMAVERA) | Recruiting | USA | ITA | GBR | FRA | ESP | DEU | AUS | 1 |
| NCT06130553 | Phase Ib/II | AZD3470 | A Study of AZD3470, a PRMT5 Inhibitor, in Patients With MTAP Deficient Advanced/Metastatic Solid Tumours (PRIMROSE) | Recruiting | USA | NLD | FRA | ESP | AUS | 3 |